Newsroom
Here you will find the latest news on shigellosis infections in the United States.
2018
Summary: This Health Alert Network (HAN) Update provides current recommendations on management and reporting of Shigella infections that have been treated with ciprofloxacin or azithromycin and resulted in possible clinical treatment failure. This is a follow-up to HAN 401: CDC Recommendations for Diagnosing and Managing Shigella Strains with Possible Reduced Susceptibility to Ciprofloxacin.
2017
Summary: This Health Advisory describes the identification of emerging Shigella strains with elevated minimum inhibitory concentration values for ciprofloxacin and outlines new recommendations for clinical diagnosis, management, and reporting, as well as new recommendations for laboratories and public health officials.
2016
Title: Multidrug-Resistant Shigellosis: An Emerging Sexually Transmitted InfectionExternal (October 2016)
Summary: Multidrug-resistant (MDR) Shigella infections may be spreading among your adult patients in a way that you might not have considered: through sexual transmission.
Title: Increasing Antimicrobial Resistance of Shigella Among Men Who Have Sex with Men in NYC Cdc-pdf[PDF – 2 pages]External (September 2016)
Summary: Shigella infections with decreased susceptibility to azithromycin are increasing among men who have sex with men (MSM) in NYC.
2015
Title: Clinical Update: Multidrug-Resistant Travelers’ Diarrhea: Counseling Travelers on Responsible Self-Treatment (April 2015)
Summary: Encourage travelers to reserve antibiotic self-treatment for severe diarrhea.
Summary: International travelers are bringing a multidrug-resistant intestinal illness to the United States and spreading it to others who have not traveled.